Shares of Zydus Lifesciences were trading in the red and 1% lower on 3 October despite the company announced receiving tentative approval from the US...
The US health regulator has provided its approval to Strides Shasun for Ranitidine tablets that are used in the treatment of intenstinal and stomach uclers...